Resistance to inhibitors of the human immunodeficiency virus type 1 integration
This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the first integrase inhibitor licensed to treat HIV-1 infection. Keywords: antiretrovirals, integrase inhibitors, raltegravir
| Egile nagusia: | |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
Elsevier
2010-09-01
|
| Saila: | Brazilian Journal of Infectious Diseases |
| Sarrera elektronikoa: | http://www.sciencedirect.com/science/article/pii/S1413867010701033 |